Cantor Fitzgerald & ADMA Biologics
1 shared events · Importance 3 · Last updated Jun 15, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Cantor Fitzgerald: Cantor Fitzgerald downgraded ADMA Biologics' stock, citing disappointment with the company's response to the Culper Research report, further contributing to the stock's decline.
ADMA Biologics: ADMA Biologics is the primary subject of the class action lawsuits and investigations due to allegations of channel stuffing, undisclosed related-party transactions, and misleading revenue growth, which caused its stock price to decline significantly.
Apr 01, 2026 · 301 articles
76
Cantor Fitzgerald downgraded ADMA BiologicsADMA Biologics Securities...
NEWSDESK
Explore this relationship live
Track how Cantor Fitzgerald and ADMA Biologics interact across events, view sentiment trends, and discover connected entities.
Open Dashboard